Loading company…
Neuroceuticals develops medical devices for cardiac care, including a vagus nerve stimulation catheter system.
Founded in 2009 and based in Tokyo, Japan, Neuroceuticals develops medical devices, including a catheter system designed to stimulate the vagus nerve and support heart function. It serves healthcare providers, hospitals, and clinics. On January 18, 2022, the company raised JPY 183.60 mn in Series B funding led by Daiwa Corporate Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in